Contract 75A50118C00015
Spero Therapeutics, Inc. · Department Of Health And Human Services · September 28, 2022
Spero Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2022 for $24.13 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost sharing contract pricing. The most recent modification was on September 4, 2025. If all options are exercised, the contract could reach $49.73 million.
Contract details
- PIID
- 75A50118C00015
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Cambridge, MA
- First action
- September 28, 2022
- Latest action
- September 4, 2025
Description
MODIFICATION P00021 THIS MODIFICATION IS BEING ISSUED TO DE-OBLIGATE CANCELLING FUNDS IN THE AMOUNT OF $61,887.86.
Modification timeline
-
September 4, 2025Mod P00021 · Supplemental Agreement For Work Within Scope$49.73M
-
July 14, 2025Mod P00020 · Other Administrative ActionMODIFICATION P00020 THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: A) UPDATE ARTICLE G.2. CONTRACTING OFFICER?S REPRESENTATIVE (COR).$49.80M
-
July 23, 2024Mod P00016 · Other Administrative ActionMODIFICATION P00016 THE PURPOSE OF THIS UNILATERAL MODIFICATION IS TO: A) CORRECT THE PERIOD OF PERFORMANCE END DATE OF CLIN 0002 TO 12/31/2025 PER THE AGREED CONTRACT TERMS. B) AS A RESULT OF THE FO…$43.37M
-
July 3, 2024Mod P00015 · Supplemental Agreement For Work Within ScopeMODIFICATION P00015 THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: A) INCREASE THE US GOVERNMENT FUNDING FOR CLIN 0005 OPTION 4 FROM $12,498,467 BY $11,697,110 TO $24,195,577 AND THE SPERO COST SH…$43.37M
-
September 28, 2022Mod P00009 · Funding Only ActionTHIS MOD SHOULD INCLUDE UPDATED SOW, GO/NO-GO MILESTONES, GANTT CHART) CHANGE THE CO FROM KATHY TO JONATHAN GONZALEZ; CHANGE KEY PERSONNEL CMO FROM DAVID TO KAMAL; REFLECT CHANGES TO IPP SYSTEM FOR IN…$31.03M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50118C00015?
Contract 75A50118C00015 is a federal contract awarded to Spero Therapeutics, Inc. by Department Of Health And Human Services on September 28, 2022 for $24.13 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75A50118C00015?
Spero Therapeutics, Inc. won contract 75A50118C00015 from Department Of Health And Human Services.
How much is contract 75A50118C00015 worth?
Contract 75A50118C00015 has obligated $24.13 million to date, with a total potential value of $49.73 million if all options are exercised.